Skip to main content
. Author manuscript; available in PMC: 2009 Sep 29.
Published in final edited form as: Oncol Nurs Forum. 2009 May;36(3):E133–E143. doi: 10.1188/09.ONF.E133-E143

Table 2.

Symptom Management Behaviors by Group at Follow-Up

Pilot 1 (N = 41) Pilot 2 (N = 20) Pilot 3 (N = 21)



IRIS Control IRIS Control IRIS





Variable n % n % n % n % n %
Discussed symptom with healthcare
  provider
16 80 13 68 9 100* 5 56 19 95
Began new medical treatment 12 60 6 32 8 89* 3 33 11 55
Improved with new treatment 8 57 6 100 7 100* 1 50 11 100
Changed self-care of symptom 15 75** 5 26 9 100** 1 11 17 85
• Found it helpful 14 93* 3 60 7 88 0 0 17 100
Talked with family and friends about
  symptom
15 75 10 53 5 56 5 56 15 75
• Found it helpful 1 87 8 57 5 100 4 80 15 100
Used other sources of information 9 45 6 32 4 44 3 33 12 60
• Found it helpful 4 100 2 67 12 100
*

p < 0.05

**

p <0.01

IRIS—individualized representational intervention to improve symptom management

Note. Follow-up measures at 10 weeks (pilot 1) or 16 weeks (pilots 2 and 3)

Note. Percentages were computed based on valid cases for each group.